Drug study with Efgartigimod for POTS

[GasDoc]

Interesting study being planned for POTS with Efgartigimod. A monoclonal antibody fragment that binds other antibodies. Think of it like a pharmaceutical immunoadsorption without the extracorporeal circuit.

More info on the drug here ⬇️

https://www.argenx.com/pipeline/efgartigimod

More info on the study here ⬇️

https://twitter.com/i/web/status/1598343648416075777

Essentially demonstrates that at least one pharmaceutical company believes that POTS is autoimmune, with autoantibodies in nature.

 

[Cort]

Nice! Thanks for that. Also used in myasthenia gravis interestingly given the Mestinon connection